These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1525682)

  • 1. [Pulmonary surfactant. Properties, relation to the respiratory distress syndrome in neonates and possibilities of its prevention and therapy].
    Kristová V; Canová R
    Bratisl Lek Listy; 1992 Jan; 93(1):41-9. PubMed ID: 1525682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of fetal lung immaturity.
    Cosmi EV; Di Renzo GC
    Fetal Ther; 1989; 4 Suppl 1():52-62. PubMed ID: 2577304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirements of perinatal prevention and treatment of respiratory distress syndrome.
    Di Renzo GC; Anceschi MM; Guidetti R; Cosmi EV
    Eur Respir J Suppl; 1989 Mar; 3():68s-72s. PubMed ID: 2662998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology.
    Jobe A
    Adv Pediatr; 1983; 30():93-130. PubMed ID: 6369946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The exogenous surfactant and its effect on the respiratory distress syndrome (RDS)].
    Brabec R; Zoban P; Tomásová H
    Cesk Fysiol; 1996 Sep; 45(3):139-45. PubMed ID: 8974827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics and outcomes of respiratory distress syndrome in term and late-preterm neonates].
    Chen A; Shi LP; Zheng JY; Du LZ
    Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):654-7. PubMed ID: 19099850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of intravenous or atomizing ambroxol for prevention of respiratory distress syndrome in preterm infants].
    Hu Q; Lian JM; Li JQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):301-3. PubMed ID: 16923362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The status of prenatal lung ripening].
    Wolff F; Bolte A
    Geburtshilfe Frauenheilkd; 1990 Mar; 50(3):171-6. PubMed ID: 2187733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung surfactant enhancement in utero.
    Di Renzo GC; Anceschi MM; Cosmi EV
    Eur J Obstet Gynecol Reprod Biol; 1989 Jul; 32(1):1-11. PubMed ID: 2670624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary surfactant and its clinical application].
    Fujiwara T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32 Suppl():236-49. PubMed ID: 7602838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory distress syndrome of the newborn infant.
    Verma RP
    Obstet Gynecol Surv; 1995 Jul; 50(7):542-55. PubMed ID: 7566832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antepartum prevention and postnatal therapy of respiratory distress syndrome].
    Schrod L; Albert P; Frauendienst-Egger G; von Stockhausen HB
    Z Geburtshilfe Perinatol; 1993; 197(4):184-7. PubMed ID: 8212769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Problems in inducing pulmonary maturation in relation to premature delivery].
    Mĕchurová A
    Ceska Gynekol; 2000 Dec; 65 Suppl 1():50-4. PubMed ID: 11394234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and late surfactant treatment in preterm triplets.
    Park YI; Delmore P; Bloom BT
    Kans Med; 1989 Dec; 90(12):335-6. PubMed ID: 2635234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant function in neonates with respiratory distress syndrome.
    Griese M; Westerburg B
    Respiration; 1998; 65(2):136-42. PubMed ID: 9580926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period.
    Parmigiani S; Panza C; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():65-73. PubMed ID: 10021719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dilemmas about the antenatal use of corticosteroids for prevention of neonatal morbidity and mortality].
    Grgić O; Matijević R
    Acta Med Croatica; 2005; 59(2):129-35. PubMed ID: 15909887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome.
    Reynolds MS; Wallander KA
    Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intrauterine infection or inflammation on fetal lung development.
    Westover AJ; Moss TJ
    Clin Exp Pharmacol Physiol; 2012 Sep; 39(9):824-30. PubMed ID: 22816773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.